EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A double‐blind trial of decoded neurofeedback intervention for specific phobias

Cody A Cushing iD, Hakwan Lau, Mitsuo Kawato, Michelle G Craske, Vincent Taschereau-Dumouchel

Psychiatry and Clinical Neurosciences · 2024

DOI: 10.1111/pcn.13726 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psychiatry and Clinical Neurosciences, 2024. Verfasst von Cody A Cushing und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, UCLA, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Phobic Disorders, Magnetic Resonance Imaging, Amygdala, Neurofeedback. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, NIMH NIH HHS, Fondation de l'Institut Universitaire en Santé Mentale de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

A new closed‐loop functional magnetic resonance imaging method called multivoxel neuroreinforcement has the potential to alleviate the subjective aversiveness of exposure‐based interventions by directly inducing phobic representations in the brain, outside of conscious awareness. The current study seeks to test this method as an intervention for specific phobia.

Methods

In a randomized, double‐blind, controlled single‐university trial, individuals diagnosed with at least two (one target, one control) animal subtype‐specific phobias were randomly assigned (1:1:1) to receive one, three, or five sessions of multivoxel neuroreinforcement in which they were rewarded for implicit activation of a target animal representation. Amygdala response to phobic stimuli was assessed by study staff blind to target and control animal assignments. Pretreatment to posttreatment differences were analyzed with a two‐way repeated‐measures anova .

Results

A total of 23 participants (69.6% female) were randomized to receive one ( n = 8), three ( n = 7), or five ( n = 7) sessions of multivoxel neuroreinforcement. Eighteen ( n = 6 each group) participants were analyzed for our primary outcome. After neuroreinforcement, we observed an interaction indicating a significant decrease in amygdala response for the target phobia but not the control phobia. No adverse events or dropouts were reported as a result of the intervention.

Conclusion

Results suggest that multivoxel neuroreinforcement can specifically reduce threat signatures in specific phobia. Consequently, this intervention may complement conventional psychotherapy approaches with a nondistressing experience for patients seeking treatment. This trial sets the stage for a larger randomized clinical trial to replicate these results and examine the effects on real‐life exposure. Clinical Trial Registration The now‐closed trial was prospectively registered at ClinicalTrials.gov with ID NCT03655262.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phobic DisordersMagnetic Resonance ImagingAmygdalaNeurofeedbackHumansFemaleMaleDouble-Blind MethodAdultYoung AdultOutcome Assessment, Health Care

Stichwörter der Autor:innen

decodingfMRIneurofeedbackphobiareinforcement

Autor:innen und Institutionen

  • Department of Psychology, UCLA, Los Angeles, California, USA.
  • RIKEN Center for Brain Science, Wako, Japan.
  • Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
  • XNef, Inc., Kyoto, Japan.
  • Department of Psychiatry and Addictology, Université de Montréal, Montreal, Québec, Canada.
  • Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal, Montreal, Québec, Canada.

ORCID-Profile: Cody A Cushing

Förderung

  • Japan Agency for Medical Research and Development
  • NIMH NIH HHS
  • Fondation de l'Institut Universitaire en Santé Mentale de Montréal
  • Innovative Science and Technology Initiative for Security
  • Fonds de Recherche du Québec - Santé
  • TWCF
  • National Institute of Mental Health
  • Templeton World Charity Foundation

Zitieren

APA

Cushing, C. A., Lau, H., Kawato, M., Craske, M. G., & Taschereau-Dumouchel, V. (2024). A double‐blind trial of decoded neurofeedback intervention for specific phobias. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13726

Vancouver

Cushing CA, Lau H, Kawato M, Craske MG, Taschereau-Dumouchel V. A double‐blind trial of decoded neurofeedback intervention for specific phobias. Psychiatry and Clinical Neurosciences. 2024. doi:10.1111/pcn.13726

BibTeX
@article{Cushing2024,
  author = {Cushing, Cody A and Lau, Hakwan and Kawato, Mitsuo and Craske, Michelle G and Taschereau-Dumouchel, Vincent},
  title = {A double‐blind trial of decoded neurofeedback intervention for specific phobias},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2024},
  doi = {10.1111/pcn.13726}
}
Kostenlos starten →